(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 6.55% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.43%.
Bausch & Lomb's revenue in 2026 is $4,976,000,000.On average, 16 Wall Street analysts forecast BLCO's revenue for 2026 to be $1,940,251,636,752, with the lowest BLCO revenue forecast at $1,838,953,358,528, and the highest BLCO revenue forecast at $2,022,069,476,856. On average, 14 Wall Street analysts forecast BLCO's revenue for 2027 to be $2,046,862,761,736, with the lowest BLCO revenue forecast at $1,921,125,388,416, and the highest BLCO revenue forecast at $2,143,556,572,768.
In 2028, BLCO is forecast to generate $2,123,367,755,080 in revenue, with the lowest revenue forecast at $1,990,900,775,864 and the highest revenue forecast at $2,251,230,267,104.